A Sputnik Moment: Russia’s Coronavirus Vaccine Could Be Ready as Early as Aug 15 to the Population

The head of the Russian sovereign wealth fund that finances research on coronavirus vaccines called the Russian race to develop the world’s first coronavirus vaccine “a Sputnik moment” and compared it to the launch of the world’s first satellite in 1957 by the Soviet Union.

Sputnik

Sputnik

Russia’s coronavirus vaccine could be administered to civilians as early as Aug. 15, Interfax cited a source at the state-run Gamaleya National Research Center for Epidemiology and Microbiology. The source said the Health Ministry will likely register the vaccine, which is still in clinical trials by August 12.

In recent months, Russia has rushed to develop a vaccine against the coronavirus.

Russia already plans to give its experimental coronavirus vaccine to health workers next month before the end of clinical trials according to health minister Mikhail Murashko.

The Russian vaccine based on adenovirus vectors, developed by military and government scientists, is in Phase II trials with plans to start the next and final phase after August 3. The vaccine “will be widely used in parallel with Phase III trials”, Interfax quoted Murashko as a statement to reporters.

Read Also: Russia Likely to Win the Race for a COVID-19 Vaccine Beating Dominant Western Pharma to the Finish Line

“Now we will see which categories will get the vaccine first. These will be mainly medical workers and people who deal with the sick. High-risk populations will also get the vaccine first,” Murashko said.

He added that the groups most at risk of COVID-19 infection, such as the elderly or those with health problems, will also be given priority with regard to the vaccine. The Minister did not estimate when this will happen.

Dozens of civilian and military volunteers who are in phase one of the vaccine trials were already released after showing good results. The Ministry of Health will decide whether the vaccine is effective on the basis of the results of the tests reported by Interfax.

Read Also: Covid-19: The Moderna Vaccine Enters the Final Phase of Clinical Trials

Murashko said that 800 people will participate in Phase 3 trials.

“In parallel, we will start increasing scale and production, and the most vulnerable groups (the elderly, diabetics and cancer patients) will also be invited to voluntary vaccination,” Interfax said.

“As a result of all this, we will have the ability to meet the demand for the vaccine”

Read Also: COVID-19: A Nasal Spray Made From Seaweed Extracts Could Prevent Infection

The Russian army said that the vaccine is “ready” after the Phase 1 trials. Health officials were more cautious by saying that the trials are still underway and the state registration process is expected to start after August 3.

The head of the Russian sovereign wealth fund, which finances the tests, said that by the end of 2020 he expects Russia to produce 200 million doses of coronavirus vaccine with foreign partners.

Read Also: 3 French Doctors Are Using Azithromycin With Zinc to Save Lives

References

Murashko: We’re planning to start vaccinating high-risk people, primarily medical workers, in Aug

Related Articles:

Coronavirus Treatments: Schweppes Tonic and Canada Dry Do Not Contain Chloroquine

Are Masks Effective in the Fight Against the Coronavirus Epidemic?

Coronavirus Pandemic: Is Global Shutdown Crucial or an Exaggerated Response?

Guideline to Self-Quarantine During the Coronavirus Outbreak

Health News

Study Shows That the Coronavirus Can Also Be Spread Through Fecal Matter

Coronavirus: Are We Heading Towards a Pandemic?

When Do Symptoms Start to Show Following Coronavirus Infection?

Coronavirus: A Concert With 4,000 People to Study How the Virus Spreads

 

Conversation

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.